FI943545A - Menetelmä tekijän VIII, jonka puhtausaste on korkea ja josta virukset on inaktivoitu, saamiseksi talteen anioninvaihtokromatografian avulla - Google Patents

Menetelmä tekijän VIII, jonka puhtausaste on korkea ja josta virukset on inaktivoitu, saamiseksi talteen anioninvaihtokromatografian avulla Download PDF

Info

Publication number
FI943545A
FI943545A FI943545A FI943545A FI943545A FI 943545 A FI943545 A FI 943545A FI 943545 A FI943545 A FI 943545A FI 943545 A FI943545 A FI 943545A FI 943545 A FI943545 A FI 943545A
Authority
FI
Finland
Prior art keywords
pct
factor viii
high purity
anion exchange
recovering high
Prior art date
Application number
FI943545A
Other languages
English (en)
Swedish (sv)
Other versions
FI943545A0 (fi
FI109908B (fi
Inventor
Monika Stadler
Horst Schwinn
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6451895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI943545(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI943545A0 publication Critical patent/FI943545A0/fi
Publication of FI943545A publication Critical patent/FI943545A/fi
Application granted granted Critical
Publication of FI109908B publication Critical patent/FI109908B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FI943545A 1992-02-01 1994-07-28 Menetelmä erittäin puhtaan, virusinaktivoidun tekijän VIII ja von Willebrand -tekijän kompleksin saamiseksi talteen anioninvaihtokromatografian avulla FI109908B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4204694 1992-02-01
DE4204694A DE4204694C3 (de) 1992-02-01 1992-02-01 Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
PCT/EP1993/000114 WO1993015105A1 (en) 1992-02-01 1993-01-20 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography
EP9300114 1993-01-20

Publications (3)

Publication Number Publication Date
FI943545A0 FI943545A0 (fi) 1994-07-28
FI943545A true FI943545A (fi) 1994-07-28
FI109908B FI109908B (fi) 2002-10-31

Family

ID=6451895

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943545A FI109908B (fi) 1992-02-01 1994-07-28 Menetelmä erittäin puhtaan, virusinaktivoidun tekijän VIII ja von Willebrand -tekijän kompleksin saamiseksi talteen anioninvaihtokromatografian avulla

Country Status (16)

Country Link
US (1) US5714590A (fi)
EP (1) EP0625161B9 (fi)
JP (1) JP3556947B2 (fi)
KR (1) KR100240310B1 (fi)
AT (1) ATE203249T1 (fi)
AU (1) AU670776B2 (fi)
DE (2) DE4204694C3 (fi)
DK (1) DK0625161T4 (fi)
ES (1) ES2157920T5 (fi)
FI (1) FI109908B (fi)
GR (1) GR3036849T3 (fi)
NO (1) NO315426B1 (fi)
PT (1) PT625161E (fi)
RU (1) RU2096414C1 (fi)
TW (1) TW362099B (fi)
WO (1) WO1993015105A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229272T2 (de) * 1991-09-05 2000-02-03 Baxter International Inc., Deerfield Topischer fibrinogenkomplex
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
EP1148063A1 (de) 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
CA2780542C (en) * 2009-11-13 2020-03-24 Grifols Therapeutics Inc. Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DE3811042A1 (de) * 1988-03-31 1989-10-19 Merck Patent Gmbh Ionenaustauscher
DE3878227D1 (de) * 1988-05-27 1993-03-18 Centre Regional De Transfusion Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3878245D1 (de) * 1988-11-05 1993-03-18 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
NO942832D0 (no) 1994-07-29
DE4204694C2 (de) 1994-02-10
FI943545A0 (fi) 1994-07-28
RU2096414C1 (ru) 1997-11-20
JPH07503241A (ja) 1995-04-06
DE69330458T3 (de) 2008-01-17
GR3036849T3 (en) 2002-01-31
AU3351793A (en) 1993-09-01
DE4204694C3 (de) 1995-10-12
US5714590A (en) 1998-02-03
EP0625161B1 (en) 2001-07-18
EP0625161B2 (en) 2007-05-16
ES2157920T3 (es) 2001-09-01
NO942832L (no) 1994-07-29
TW362099B (en) 1999-06-21
EP0625161A1 (en) 1994-11-23
JP3556947B2 (ja) 2004-08-25
EP0625161B9 (en) 2007-09-19
FI109908B (fi) 2002-10-31
NO315426B1 (no) 2003-09-01
AU670776B2 (en) 1996-08-01
KR100240310B1 (ko) 2000-01-15
ES2157920T5 (es) 2007-12-16
KR950700925A (ko) 1995-02-20
PT625161E (pt) 2001-10-31
WO1993015105A1 (en) 1993-08-05
DE4204694A1 (de) 1993-08-12
ATE203249T1 (de) 2001-08-15
DK0625161T3 (da) 2001-09-24
DE69330458D1 (de) 2001-08-23
DK0625161T4 (da) 2007-09-03
DE69330458T2 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
FI943545A (fi) Menetelmä tekijän VIII, jonka puhtausaste on korkea ja josta virukset on inaktivoitu, saamiseksi talteen anioninvaihtokromatografian avulla
AU7567887A (en) Process for the preparation of taxol and 10-deacetyltaxol
NO925035D0 (no) Nye polyamider og gjenstander fremstilt derav
FR2730240B1 (fi)
EP0272665A3 (en) Aminourethanes, process for their preparation and their use
SE9300140L (sv) Fast bärare med modifierad yta varvid modifikationen åstadkommes genom en primer innehållande en polysackarid och förfarande för framställning av en sådan bärare
CA2107353A1 (en) Uv curable clearcoat compositions and process
KR840009069A (ko) 향정신성 펩티드류의 제조 방법
RU94035758A (ru) Способ выделения высокоочищенного фактора yiii
NO903704L (no) Nye derivater av deoksy-2'-uridin substituert i 5-, 3' eller 5'-posisjon med alfa-aminoacyl-grupper, samt fremgangsmaate for fremstilling av slike forbindelser, og medikamenter som inneholder dem.
MX9302408A (es) Proceso de alcoxilacion.
FI941094A0 (fi) Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
AU6295396A (en) Method of purification by extraction from a liquid medium
AU6918291A (en) Coating material, process for producing it and its use
DE19680202D2 (de) Arzneistoffe zur selektiven Bekämpfung von Tumorgewebe
CA2137889A1 (fr) Nouveaux analogues de l'eburnane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AR241137A2 (es) "procedimiento para preparar beta-metilen-2 o 3-tiofenetanamina".
MA22868A1 (fr) Procede de preparation d'amines polyoxyalkylees .
AU5522794A (en) New angiopeptin cyclopeptide compounds, process for the preparation thereof, and pharmaceutical compositios containing them
DE59309480D1 (de) Verfahren zur herstellung einer physikalisch stabilen, kristallinen gamma-modifikation von para-aminobenzolsulfonamid
WO1997019916A3 (en) Bisazo compounds, intermediates thereof, process for synthesizing the same and therapeutic agent for viral infection containing the same
JPS5939886A (ja) フマロピマ−ル酸トリグリシジルエステル
TH1767A (th) สารประเภท 1,2,3,4 เท็ทตระไบโตร-1-อะมิโนเมทธิล-4-เฟนนิล ไอโซควิโพลิน และกรรมวิธีในการเตรียม
IT1243789B (it) Membrane asimmetriche e omogenee a base di polifosfazeni, e procedimento per la loro preparazione; e procedimento per la separazione di gas
GEP20002295B (en) Dialkyl Ethers Having Terminal Carboxy or Tetrazole Groups

Legal Events

Date Code Title Description
MM Patent lapsed